The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile

OBJECTIVE: We aimed to investigate the effect of switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) on the hepatic safety and metabolic profile. METHODS: Consecutive HIV patients, enrolled in the Surveillance Cohort Long-term Toxicity Antiretrovirals/Antivirals (SCOLTA...

Descripción completa

Detalles Bibliográficos
Autores principales: Squillace, Nicola, Ricci, Elena, Menzaghi, Barbara, De Socio, Giuseppe Vittorio, Passerini, Simone, Martinelli, Canio, Mameli, Maria Sabrina, Maggi, Paolo, Falasca, Katia, Cordier, Laura, Celesia, Benedetto Maurizio, Salomoni, Elena, Di Biagio, Antonio, Pellicanò, Giovanni Francesco, Bonfanti, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751319/
https://www.ncbi.nlm.nih.gov/pubmed/33364747
http://dx.doi.org/10.2147/DDDT.S274307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751319/
https://www.ncbi.nlm.nih.gov/pubmed/33364747
http://dx.doi.org/10.2147/DDDT.S274307

Ejemplares similares